B of A Securities Maintains Buy Rating for Liquidia: Here's What You Need To Know
Portfolio Pulse from Benzinga Insights
B of A Securities has reaffirmed its Buy rating on Liquidia (NASDAQ:LQDA) and increased its price target from $13.00 to $15.00. Liquidia's shares have risen 3.46% in the last 24 hours to $11.07. The new price target suggests a potential upside of 35.5%. Liquidia is a biopharmaceutical company focusing on pulmonary hypertension treatments, utilizing its proprietary PRINT technology.
December 21, 2023 | 5:00 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
B of A Securities maintains a Buy rating on Liquidia and raises the price target to $15, indicating a significant potential upside from the current price.
The reaffirmation of a Buy rating and an increased price target by a reputable analyst firm like B of A Securities typically instills confidence in investors and can lead to a positive short-term price movement. The 35.5% potential increase indicated by the new price target is substantial, suggesting a strong conviction in the company's future performance.
CONFIDENCE 90
IMPORTANCE 85
RELEVANCE 100